Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT) closed at $1.23 on November 10, 2026, down 0.81% on the day. The stock trades 93.7% below its 52-week high of $19.50 and 27.3% above its 52-week low of $0.966. Over the past year, it gained 6.0%. Matinas BioPharma Holdings, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 251 trading sessions since November 10, 2025, MTNB closed higher on 110 days (44%). Its best day was July 27, 2026 (+37.76%) and its worst was July 13, 2026 (-36.42%). The stock moved 10% or more in a single session 35 times. It opened at least 5% above the previous day's high 2 times.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.
Find more stocks like MTNB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.